Skip to content

Envoy Medical COCH Deferred Tax Liabilities, Gross

Deferred Tax Liabilities, Gross at other companies

State Street logo
State StreetSTT
$972M+5.8%
MSCI logo
MSCIMSCI
$245.53M+29.4%
Keysight Technologies logo
Keysight TechnologiesKEYS
$459M+30.0%
Arthur J. Gallagher logo
Arthur J. GallagherAJG
$2.74B+240%
PepsiCo logo
PepsiCoPEP
$4.66B+13.0%
L3Harris Technologies logo
L3Harris TechnologiesLHX
$3.28B-8.9%

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%
Debt / equity0.1×
Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilities.

The official record: Envoy Medical’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's deferred tax liabilities, gross.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's deferred tax liabilities, gross?
Envoy Medical (COCH) reported deferred tax liabilities, gross of $808K in Q4 2025.